Safety, tolerability, and efficacy of NLY01 in early untreated parkinsons disease: a randomised, double-blind, placebo-controlled trial
Pack size: 100ml Flavour: Natural Gender: For Men, For Women Dairy Free, Gluten Free, Vegan, Vegetarian, Wheat Free Storage Store in a cool, dark place out of reach of children Disclaimer Food supplements should not be used as a substitute for a varied diet
If you experience any unusual or severe symptoms, stop using the medication and contact your doctor or seek medical attention promptly
Key findings from the Phase 2 trial included: Dose-dependent reductions in body weight across all active treatment arms Significant improvements in waist circumference, a key marker of visceral adiposity Reductions in fasting insulin levels and HbA1c Improvements in lipid profiles, including triglycerides Phase 3 trials are currently ongoing and are expected to include larger, more diverse populations with more granular subgroup analyses, including sex-specific data
Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, Sethumadhavan S, Woo HK, Jang HG, Jha AK, Chen WW, Barrett FG, Stransky N, Tsun ZY, Cowley GS, Barretina J, Kalaany NY, Hsu PP, Ottina K, Chan AM, Yuan B, Garraway LA, Root DE, Mino-Kenudson M, Brachtel EF, Driggers EM, Sabatini DM
NAC (N-Acetyl Cysteine) is a precursor it provides cysteine, which your body uses to make glutathione
